Home > Financial Ratios > ORCHID PHARMA

ORCHID PHARMA
EBIT Growth

    Back to All Ratios
ORCHID PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for ORCHID PHARMA
Please provide your vote to see the results

ORCHID PHARMA Last 5 Year EBIT Growth History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   EBIT Growth(%) 476.0245.5465.52-264.06185.78

What is the latest EBIT Growth ratio of ORCHID PHARMA ?

The latest EBIT Growth ratio of ORCHID PHARMA is 476.02 based on Mar2023 Consolidated results.
Year EBIT Growth
Mar2023476.02
Mar202245.54
Mar202165.52
Mar2020-264.06
Mar2019185.78

How is EBIT Growth of ORCHID PHARMA Trending?

Years EBIT Growth % Change
Mar2023 476.02
945.28
Mar2022 45.54
-30.49
Mar2021 65.52
Positive
Mar2020 -264.06
Negative
Mar2019 185.78 -

Other Financial Ratios of ORCHID PHARMA


Compare EBIT Growth ratio of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹5,508.3 Cr 2.6% 1.9% 175% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹365,167.0 Cr 2.6% -4.7% 54.7% Stock Analytics
CIPLA ₹113,645.0 Cr 4.4% -4.4% 54.7% Stock Analytics
DIVIS LABORATORIES ₹105,890.0 Cr 5.8% 17.7% 24.8% Stock Analytics
DR REDDYS LABORATORIES ₹104,987.0 Cr 5.7% 2.7% 29.3% Stock Analytics
ZYDUS LIFESCIENCES ₹96,950.6 Cr 0.4% -5.4% 82.7% Stock Analytics


ORCHID PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

2.6%

1.9%

175%

SENSEX

1.4%

2.5%

24.3%


You may also like the below Video Courses